Prostate-specific antigen doubling time: A potential surrogate end point in hormone-refractory prostate cancer - Reply

被引：0
|
作者：
Dawson, NA [1 ]
机构：
[1] Walter Reed Army Med Ctr, Washington, DC 20307 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1999年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1646 / 1646
页数：1
相关论文
共 50 条
  • [21] Survival analyses overview in hormone-refractory prostate cancer clinical trials in the prostate-specific antigen era
    Sartor, Oliver
    [J]. CLINICAL GENITOURINARY CANCER, 2007, 5 (07) : 420 - 421
  • [22] Prostate-specific antigen doubling time as a prognostic marker in prostate cancer
    James A Eastham
    [J]. Nature Clinical Practice Urology, 2005, 2 : 482 - 491
  • [23] Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer
    D'Amico, AV
    Moul, J
    Carroll, PR
    Sun, L
    Lubeck, D
    Chen, MH
    [J]. JOURNAL OF UROLOGY, 2005, 173 (05): : 1572 - 1576
  • [24] Prostate-specific antigen doubling time as a prognostic marker in prostate cancer
    Eastham, JA
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (10): : 482 - 491
  • [25] Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel
    Olbert, Peter Jochen
    Hegele, Axel
    Kraeuter, Petra
    Heidenreich, Axel
    Hofmann, Rainer
    Schrader, Andres Jan
    [J]. ANTI-CANCER DRUGS, 2006, 17 (08) : 993 - 996
  • [26] Prostate-Specific Antigen Doubling Time as a Predictor of Gleason Grade in Prostate Cancer
    Nowroozi, Mohammad Reza
    Zeighami, Shahryar
    Ayati, Mohsen
    Jamshidian, Hassan
    Ranjbaran, Ali Reza
    Moradi, Asaad
    Afsar, Firuzeh
    [J]. UROLOGY JOURNAL, 2009, 6 (01) : 27 - 30
  • [27] Prostate-specific antigen levels and clinical response to flutamide as the second hormone therapy for hormone-refractory prostate carcinoma
    Fujikawa, K
    Matsui, Y
    Fukuzawa, S
    Takeuchi, H
    [J]. EUROPEAN UROLOGY, 2000, 37 (02) : 218 - 222
  • [28] Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer
    Perambakam, S
    Xue, BH
    Sosman, JA
    Peace, DJ
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (05) : 263 - 270
  • [29] Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer
    Kantoff, PW
    Halabi, S
    Farmer, DA
    Hayes, DF
    Vogelzang, NA
    Small, EJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3025 - 3028
  • [30] Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer
    Supriya Perambakam
    Bao-Hua Xue
    Jeffrey A. Sosman
    David J. Peace
    [J]. Cancer Immunology, Immunotherapy, 2002, 51 : 263 - 270
12345